Scinai Immunotherapeutics (SCNI) Change in Accured Expenses (2018 - 2024)
Scinai Immunotherapeutics' (SCNI) quarterly Change in Accured Expenses came in at -$51000.0 in Q3 2024, up 78.02% year-on-year from -$28648.9 in Q4 2023, and down 227.5% quarter-over-quarter from $40000.0 in Q2 2024.
Scinai Immunotherapeutics (SCNI) Change in Accured Expenses (2018 - 2024) Analysis & Trends
Scinai Immunotherapeutics has disclosed Change in Accured Expenses across 3 years of filings, most recently posting -$51000.0 for Q3 2024.
- Change in Accured Expenses for Q3 2024 came in at -$51000.0, up 78.02% year-over-year; the trailing twelve-month figure through Sep 2024 was -$482000.0 (up 12.04% YoY), and the FY2021 annual result was $754000.0, changed N/A from the prior year.
- Change in Accured Expenses came in at -$51000.0 for Q3 2024 at Scinai Immunotherapeutics, down from $40000.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $40000.0 in Q2 2024 to a low of -$369000.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 931,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 644,700.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 70.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Scinai Immunotherapeutics | 3.02 Bn | 988.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -51,000.00 |
| Sep 30, 2024 | -51,000.00 |
| Jun 30, 2024 | 40,000.00 |
| Jun 30, 2024 | 40,000.00 |
| Mar 31, 2024 | -239,000.00 |
| Mar 31, 2024 | -239,000.00 |
| Sep 30, 2023 | -232,000.00 |
| Sep 30, 2023 | -232,000.00 |
| Jun 30, 2023 | 22,000.00 |
| Jun 30, 2023 | 22,000.00 |
| Mar 31, 2023 | -369,000.00 |
| Mar 31, 2023 | -369,000.00 |
| Mar 31, 2018 | 31,000.00 |
| Mar 31, 2018 | 31,000.00 |